MX2009004294A - Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona. - Google Patents

Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona.

Info

Publication number
MX2009004294A
MX2009004294A MX2009004294A MX2009004294A MX2009004294A MX 2009004294 A MX2009004294 A MX 2009004294A MX 2009004294 A MX2009004294 A MX 2009004294A MX 2009004294 A MX2009004294 A MX 2009004294A MX 2009004294 A MX2009004294 A MX 2009004294A
Authority
MX
Mexico
Prior art keywords
octahydrobenzo
benzyl
methyl
salt
oxazol
Prior art date
Application number
MX2009004294A
Other languages
English (en)
Spanish (es)
Inventor
Fabio Neggiani
Laura Dini
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Publication of MX2009004294A publication Critical patent/MX2009004294A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2009004294A 2006-11-02 2007-10-31 Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona. MX2009004294A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002102A ITMI20062102A1 (it) 2006-11-02 2006-11-02 Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
PCT/IB2007/003292 WO2008053326A1 (en) 2006-11-02 2007-10-31 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Publications (1)

Publication Number Publication Date
MX2009004294A true MX2009004294A (es) 2009-05-08

Family

ID=39145485

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009004294A MX2009004294A (es) 2006-11-02 2007-10-31 Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona.
MX2009004293A MX2009004293A (es) 2006-11-02 2007-10-31 Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009004293A MX2009004293A (es) 2006-11-02 2007-10-31 Una sal de 3-bencil-2-metil-2,3,3a,4,5,6,7,7a-octahidrobenzo[d]iso xasol-4-ona.

Country Status (20)

Country Link
US (2) US20100069450A1 (enExample)
EP (2) EP2094674B1 (enExample)
JP (2) JP2010509309A (enExample)
KR (2) KR20090077014A (enExample)
CN (2) CN101535282A (enExample)
AT (2) ATE502021T1 (enExample)
AU (2) AU2007315833A1 (enExample)
BR (2) BRPI0718391A2 (enExample)
CA (2) CA2667513A1 (enExample)
DE (2) DE602007013801D1 (enExample)
HR (2) HRP20090477A2 (enExample)
IL (2) IL198444A0 (enExample)
IT (1) ITMI20062102A1 (enExample)
MX (2) MX2009004294A (enExample)
NO (2) NO20092114L (enExample)
NZ (2) NZ577311A (enExample)
RS (2) RS20090388A (enExample)
RU (2) RU2009120724A (enExample)
WO (2) WO2008053326A1 (enExample)
ZA (2) ZA200903618B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112142A1 (en) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
WO2016123275A1 (en) * 2015-01-30 2016-08-04 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
ZA200903810B (en) 2010-07-28
RS20090389A (sr) 2010-12-31
MX2009004293A (es) 2009-05-08
AU2007315833A1 (en) 2008-05-08
HRP20090477A2 (hr) 2009-11-30
KR20090082452A (ko) 2009-07-30
US20100069451A1 (en) 2010-03-18
HRP20090470A2 (hr) 2009-11-30
NZ577311A (en) 2010-10-29
EP2094675B1 (en) 2011-04-06
EP2094674B1 (en) 2011-03-16
RU2009120667A (ru) 2010-12-10
EP2094674A1 (en) 2009-09-02
BRPI0718391A2 (pt) 2013-11-26
IL198443A0 (en) 2010-02-17
NO20092115L (no) 2009-05-29
DE602007013801D1 (de) 2011-05-19
WO2008053326A1 (en) 2008-05-08
US20100069450A1 (en) 2010-03-18
EP2094675A1 (en) 2009-09-02
CA2667513A1 (en) 2008-05-08
AU2007315832A1 (en) 2008-05-08
RS20090388A (sr) 2010-12-31
JP2010509310A (ja) 2010-03-25
RU2009120724A (ru) 2010-12-10
CN101535282A (zh) 2009-09-16
IL198444A0 (en) 2010-02-17
NO20092114L (no) 2009-05-29
ATE504578T1 (de) 2011-04-15
DE602007013278D1 (de) 2011-04-28
CN101535281A (zh) 2009-09-16
ZA200903618B (en) 2010-07-28
JP2010509309A (ja) 2010-03-25
ITMI20062102A1 (it) 2008-05-03
CA2667515A1 (en) 2008-05-08
WO2008053325A1 (en) 2008-05-08
BRPI0718392A2 (pt) 2013-11-26
ATE502021T1 (de) 2011-04-15
NZ577978A (en) 2010-10-29
KR20090077014A (ko) 2009-07-13

Similar Documents

Publication Publication Date Title
SE0303180D0 (sv) Novel compounds
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
ATE431340T1 (de) N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1- piperidincarboxamid-derivate und verwandte verbindungen als cgrp-antagonisten zur behandlung von kopfschmerzen
ATE542818T1 (de) Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
WO2008060621A3 (en) Aminopyrrolidines as chemokine receptor antagonists
ZA200903810B (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
PL1716152T3 (pl) Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych
DE602006021645D1 (de) Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten
ATE463497T1 (de) Neues 1,4-diaza-bicycloä3.2.2ünonyl-oxadiazolyl- derivat und seine medizinische verwendung
ATE289310T1 (de) Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
WO2009025839A3 (en) Phosphodiesterase 10 inhibitors
ATE354358T1 (de) Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
MY124844A (en) 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
DE60111464D1 (de) Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
ATE502945T1 (de) Ä ä5- ( phenyl) - 6- phenylpyrrolo ä2,1-füä2,1, 4ütriazin-4-ylüaminoü carbonsäurederivate und verwandte verbindungen als prostazyklin (pgi2) ip-rezeptor aktivatoren zur behandlung von kardiovaskulären erkrankungen
GB0322510D0 (en) Novel compounds
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
EA200600688A1 (ru) Арилинденпиридины и арилинденпиримидины и их применение в качестве антагонистов аденозинового рецептора а2а
EA200600563A1 (ru) Способ получения рензаприда и его промежуточных соединений
HK1131142A (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
HK1131143A (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ATE334680T1 (de) 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel
MX2007003922A (es) Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central.
PL2186782T3 (pl) Sposób oczyszczania produktów znakowanych radioaktywnie z zastosowaniem zmiatacza na stałym nośniku
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers

Legal Events

Date Code Title Description
FA Abandonment or withdrawal